Whether it’s forgetting a name or where we placed our keys and cell phone, memory lapses can be especially worrying for aging adults with…
UPDATE: 3 March 2024, 8:26 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
For retired neurologist Daniel Gibbs, an Alzheimer’s diagnosis gave him not only a sense of relief, but a new lifestyle: one of healthier living,…
Retired neurologist Daniel Gibbs speaks about his own Alzheimer’s diagnosis, his unusual and severe case of side effects in aducanumab (Aduhelm) clinical trials, and…
In light of last week’s long-awaited FDA decision on experimental Alzheimer’s treatment aducanumab, a panel of clinical trials experts looks at why Alzheimer’s drug…
Imran Sherwani, olympic gold medalist, was diagnosed with early-onset Alzheimer’s in 2019, and revealed his diagnosis this month. Sherwani revels in the life he’s…
The FDA’s approval of Biogen’s new anti-amyloid drug Aduhelm was a landmark moment for Alzheimer’s — and it comes with no small amount of…
UPDATE: 3 March 2024, 8:33 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Looking for answers about Alzheimer’s treatment Aduhelm (generic name aducanumab)? Here’s a primer on what it is, what it does, and more, according to…
Cinical trial investigators for aducanumab (Aduhelm) discuss the significance of the drug’s recent FDA approval, the controversy surrounding its efficacy, and the uncertainty ahead….
Geri Taylor, a participant in the aducanumab (Aduhelm) clinical trial, and her husband Jim share insights about taking part in the research. UPDATE: 3…
Image: Phil Gutis receives an aducanumab infusion while carrying out his “silly shoe challenge.” Phil Gutis reflects on the significance of participating in the…
In case you missed them, our editors and contributors round up their most recommended reads from the month of May in Being Patient Reads…
Expressive arts like music, painting, and even dance have the potential to evoke powerful emotion and long-buried memories in people living with Alzheimer’s. For…
Biogen’s aducanumab — a human antibody-based drug that targets beta-amyloid plaques, which are found in the brains of people with Alzheimer’s — has gone…